Lifecentre Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.60 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.90 M
- Satisfied Charges ₹ 4.90 M
- Revenue Growth -20.79%
- Profit Growth -1762.48%
- Ebitda -116.87%
- Net Worth -61.37%
- Total Assets -14.28%
About Lifecentre Pharmaceuticals
Lifecentre Pharmaceuticals Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 September 2013 and has a history of 11 years and four months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.60 M.
The company currently has active open charges totaling ₹4.90 M. The company has closed loans amounting to ₹4.90 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Agarwal, Priti Agarwal, and Jitendra Agarwal serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900WB2013PTC197657
- Company No.
197657
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Lifecentre Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Agarwal  | Director | 27-Sep-2013 | Current |
| Priti Agarwal | Director | 21-May-2015 | Current |
| Jitendra Agarwal | Director | 27-Sep-2013 | Current |
Financial Performance of Lifecentre Pharmaceuticals.
Lifecentre Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.79% decrease. The company also saw a substantial fall in profitability, with a 1762.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 61.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lifecentre Pharmaceuticals?
In 2020, Lifecentre Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Koteshwar Chemfood Industries Private LimitedJitendra Agarwal is a mutual person
Skdj Construction LlpSunil Agarwal is a mutual person
- Sgmp Marketing Private Limited
Priti Agarwal and Jitendra Agarwal are mutual person
- Soar High Projects Llp
Priti Agarwal is a mutual person
Charges (Loans)
₹4.90 M
₹4.90 M
Charges Breakdown by Lending Institutions
- Others : 0.49 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2019 | Others | ₹4.90 M | Open |
| 19 Sep 2014 | Punjab National Bank | ₹4.90 M | Satisfied |
How Many Employees Work at Lifecentre Pharmaceuticals?
Unlock and access historical data on people associated with Lifecentre Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifecentre Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifecentre Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.